Skip to content

Dermogenesis With Mesenchymal Stem Cells

Dermogenesis With Mesenchymal Stem Cells: A Fabulous Remedy For Post Acne Depressed Spots

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06135519
Acronym
MSCs
Enrollment
20
Registered
2023-11-18
Start date
2023-07-23
Completion date
2024-02-22
Last updated
2024-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermal Regeneration

Brief summary

Dermogenesis With Mesenchymal Stem Cells in treating Post Acne Depressed Spots

Detailed description

management at two different stages of the course of the disease. First one at the stage of active disease which needs cleansers, antibiotics, retinoids, anti inflammatory agents and hormonal manipulation. Once active disease is over, patients report to clinician with depressed spots which are caused by localized dermal disruption and fat atrophy post inflammation or spontaneous epithelial rupture or scratching by the patient. These acne spots are hard to treat due to many reasons. Firstly, excision is difficult as size of most of them is small and they are in a large in number. Secondly, filling with and without subcision is not adequately addressing the deformity. Currently, a combination of filling with synthetic filler or fat and resurfacing by peeling, LASER or dermabrasion is in practice. In-spite of all, a treatment is still required to address post acne spots (Ice Spec Spots) adequately.

Interventions

PROCEDUREAutologous Mesenchymal stem cells injection

Autologous Mesenchymal stem cells will be seperated from harvested fat and injected in acne scars

PROCEDUREHomogenized fat injection

Autologous fat will be harvested, homogenized and injected.

Sponsors

King Edward Medical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Group A with MSCs Group B with Fat

Eligibility

Sex/Gender
ALL
Age
No minimum to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Acne spots

Exclusion criteria

* Active acne

Design outcomes

Primary

MeasureTime frameDescription
Dermal thickness3 monthson microscopy of biopsy section

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026